Elotuzumab, sold under the brand name Empliciti, is a humanized IgG1 monoclonal antibody medication used in combination with lenalidomide and dexamethasone...
14 KB (1,196 words) - 14:55, 2 July 2024
Cancer immunotherapy (section Elotuzumab)
protease inhibitor. Administration of elotuzumab is done intravenously. Each intravenous injection of elotuzumab should be premedicated with dexamethasone...
92 KB (12,540 words) - 18:53, 23 December 2024
homophilic way. SLAMFs are potential targets for immunotherapy. For example, elotuzumab is an anti-SLAMF7 humanized monoclonal antibody used to treat multiple...
10 KB (1,117 words) - 12:24, 14 January 2024
maraleucel) CeeNU (lomustine) Droxia/Hydrea (hydroxycarbamide) Empliciti (Elotuzumab) Erbitux (cetuximab) Etopophos (etoposide) Ixempra (ixabepilone) Lysodren...
97 KB (7,702 words) - 19:32, 22 December 2024
double refractory to a proteasome inhibitor and an immunomodulatory agent elotuzumab: an immunostimulatory humanized monoclonal antibody against SLAMF7 (also...
131 KB (13,509 words) - 06:14, 3 December 2024
elmustine (INN) elnadipine (INN) elocalcitol (INN) Elocon elopiprazole (INN) elotuzumab (USAN) Eloxatin elpetrigine (USAN, INN) elranatamab (INN) Elrexfio elsamitrucin...
8 KB (435 words) - 09:34, 27 December 2024
lines. There are newer medications (ixazomib, carfilzomib, daratumumab, elotuzumab) under research for the treatment of multiple myeloma that can help to...
30 KB (3,354 words) - 16:25, 7 December 2024
injury and multiple sclerosis Elgemtumab mab human ERBB3 (HER3) cancer Elotuzumab Empliciti mab humanized SLAMF7 Y multiple myeloma Elsilimomab mab mouse...
138 KB (4,154 words) - 05:18, 17 December 2024
Cemiplimab Cosibelimab Daratumumab Dinutuximab beta Dostarlimab Durvalumab Elotuzumab Enfortumab vedotin Epcoritamab Inotuzumab ozogamicin Ipilimumab Isatuximab...
12 KB (821 words) - 06:14, 23 December 2024
myeloma Nivolumab Bristol-Myers Squibb advanced renal cell carcinoma Elotuzumab Bristol-Myers Squibb multiple myeloma Sebelipase alfa Alexion Pharmaceuticals...
42 KB (240 words) - 05:05, 7 January 2025
Brentuximab vedotin L01FX06 Dinutuximab beta L01FX07 Blinatumomab L01FX08 Elotuzumab L01FX09 Mogamulizumab L01FX10 Olaratumab L01FX11 Bermekimab L01FX12 Tafasitamab...
13 KB (935 words) - 04:36, 23 December 2024
Complement component 5 Paroxysmal nocturnal hemoglobinuria 125166 Link elotuzumab Empliciti Bristol-Myers Squibb 11/30/2015 intravenous humanized SLAMF7...
59 KB (4,170 words) - 07:03, 20 October 2024
of malignant plasma cells from delayed or even cryopreserved samples. Elotuzumab is an antibody that targets this protein. GRCh38: Ensembl release 89:...
7 KB (846 words) - 01:16, 30 January 2023
pelidotin Dacetuzumab§ Demcizumab§ Dalotuzumab§ Denintuzumab mafodotin§ Elotuzumab Emactuzumab Emibetuzumab§ Enoblituzumab§ Epcoritamab Etaracizumab§ Farletuzumab§...
5 KB (368 words) - 15:29, 21 August 2024
Cemiplimab Cosibelimab Daratumumab Dinutuximab beta Dostarlimab Durvalumab Elotuzumab Enfortumab vedotin Epcoritamab Inotuzumab ozogamicin Ipilimumab Isatuximab...
12 KB (758 words) - 23:46, 14 March 2024
pelidotin Dacetuzumab§ Demcizumab§ Dalotuzumab§ Denintuzumab mafodotin§ Elotuzumab Emactuzumab Emibetuzumab§ Enoblituzumab§ Epcoritamab Etaracizumab§ Farletuzumab§...
3 KB (129 words) - 01:04, 19 July 2023
(NCT00803374), rituximab (NCT01775631, NCT02420938), cetuximab (NCT02110082), and elotuzumab (NCT02252263), nivolumab (NCT02253992) for metastatic solid tumors, NSCLC...
12 KB (1,121 words) - 19:12, 14 October 2024
such as monoclonal antibodies (anti-CD38 — daratumumab or anti-CS1 — elotuzumab) or the kinesin protein inhibitor Arry-520." A 2016 phase 1 dose-escalation...
11 KB (1,110 words) - 22:35, 26 August 2023
pelidotin Dacetuzumab§ Demcizumab§ Dalotuzumab§ Denintuzumab mafodotin§ Elotuzumab Emactuzumab Emibetuzumab§ Enoblituzumab§ Epcoritamab Etaracizumab§ Farletuzumab§...
4 KB (241 words) - 13:42, 14 July 2024